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he sympathetic nervous system of the heart is critically involved in the maintenance of cardiovascular homoeostasis by regulating cardiac contractility, conduction, heart frequency and peripheral vasoconstriction. 1 It has been shown that a dysfunctional cardiac sympathetic nervous system exerts detrimental effects on the structural and functional integrity of the myocardium, leading to a marked increase in the morbidity and mortality of patients with cardiac disease. 2 Myocardial imaging with 123 I-metaiodobenzylguanidine (MIBG), an analog of norepinephrine, is useful for detecting abnormalities of the sympathetic nervous system of the heart in patients with heart failure. 3, 4 Because the washout rate (WR) evaluated by 123 I-MIBG scintigraphy is known to reflect the degree of cardiac sympathetic nerve activity, 4 a high WR has useful prognostic value in patients with cardiovascular disease. 5, 6 
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On the other hand, evaluation of baroreflex sensitivity (BRS), obtained from non-invasive continuous arterial pressure, is known to be useful for assessing autonomic control of the cardiovascular system. 7 Previous reports have indicated that BRS has long-term predictive value in patients not only with cardiovascular disease, 7 but also with type 2 diabetes mellitus (T2DM). 8, 9 However, no studies have examined whether the combined assessment of BRS and 123 I-MIBG scintigraphy could be useful for predicting major adverse events in T2DM patients. Accordingly, the study by Murozono et al 10 in this issue of the Journal is interesting because it evaluates whether the combination of BRS and 123 I-MIBG scintigraphy is predictive for major adverse cerebral and cardiovascular events (MACCE) in patients with T2DM. The study was based on 165 T2DM patients without structural heart disease who had undergone both BRS and 123 I-MIBG scintigraphy. The patients were divided into 3 groups based on the "BRS-MIBG combination score" as follows: score 0, patients with both preserved BRS and low WR on 123 I-MIBG imaging; score 1, patients with either depressed BRS or high WR; and score 2, patients with both depressed BRS and high WR. During a mean of 4.7 years of follow-up, 19 of the 165 patients developed MACCE. Cardiovascular death accounted for 4 cases, another 2 cases were nonfatal myocardial infarctions, 4 cases were coronary revascularizations, 6 cases were strokes, and the remaining 3 cases were congestive heart failures. The incidence of MACCE was significantly higher in the group with BRS-MIBG combination score 2 (33.3%) than in that with score 0 (3.7%) or score 1 (12.3%). Multivariate Cox proportional hazards regression analysis revealed that BRS-MIBG combination score was the best and only incremental predictor of MACCE (hazard ratio 3.42, 95% confidence interval 1.54-7.85, P=0.0025). Finally, Kaplan-Meier analyses showed that MACCE-free ratio was significantly lower in the group with score 2 than in that with score 0 (P=0.0001). Accordingly, the study has shown for the first time that the BRS-MIBG combination score could be used for risk stratification of patients with T2DM without structural heart disease.
Although this study clearly demonstrated the prognostic value of the combination of BRS and 123 I-MIBG scintigraphy in T2DM patients, some limitations need to be considered. First, the level of plasma norepinephrine and its spillover were not measured in the study. As these variables are predictive for adverse outcomes in the failing human heart, 2 it would be interesting to evaluate the relation between plasma norepinephrine level (or its spillover) and cardiac 123 I-MIBG imaging variables. Second, the reproducibility of the 123 I-MIBG imaging variables was not assessed. Although the authors used a standard approach for their assessment of 123 I-MIBG imaging parameters, intra-and interobserver reproducibility analyses could have considerably improved the robustness of the current analyses. Finally, the study evaluated only 1-time evaluation of 123 I-MIBG scintigraphy, but it is well-known that imaging results improve after medical treatments. 11-13 Recent reports have demonstrated that serial 123 I-MIBG scintigraphic studies have more prognostic value than a 1-time scan in heart failure patients. 14, 15 Despite these study limitations, the study by Murozono et
